Cargando…
Ocrelizumab-induced vulvovaginal pyoderma gangrenosum in a patient with relapsing-remitting multiple sclerosis
Autores principales: | Klumpp, Annika, Luessi, Felix, Engel, Sinah, Weidenthaler-Barth, Beate, Becker, Detlef, Grabbe, Stephan, Schepler, Hadrian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9463556/ https://www.ncbi.nlm.nih.gov/pubmed/36097621 http://dx.doi.org/10.1016/j.jdcr.2022.08.005 |
Ejemplares similares
-
Vulvovaginal pyoderma gangrenosum in association with rituximab
por: Maloney, Catherine, et al.
Publicado: (2018) -
Vulvovaginal pyoderma gangrenosum associated with rituximab use in 2 patients with rheumatoid arthritis
por: Sotzen, Jason R., et al.
Publicado: (2021) -
Endocarditis following ocrelizumab in relapsing-remitting MS
por: Faissner, Simon, et al.
Publicado: (2020) -
Tumefactive demyelination in a patient with relapsing-remitting MS on ocrelizumab
por: Moreira Ferreira, Vanessa F., et al.
Publicado: (2019) -
Penile pyoderma gangrenosum
por: Philip, Mariam, et al.
Publicado: (2013)